Fighting transplant infections with a Patient's own donor cells
NCT ID NCT01325636
Summary
This study tested a new cell therapy for patients who develop dangerous viral infections after a stem cell transplant and don't respond to standard antiviral drugs. Doctors collected special immune cells (T cells) from the patient's original stem cell donor, grew cells that could fight either CMV or adenovirus, and injected them into the patient. The main goal was to see if this treatment could reduce the amount of CMV virus in the blood within 21 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotherapy department, Hôpital Necker - Enfants Malades
Paris, 75743, France
Conditions
Explore the condition pages connected to this study.